(Q51483484)

5 April 2018

title

Postmarketing surveillance of acarbose treatment in Taiwanese patients with type 2 diabetes mellitus. (English)

1 reference

5 April 2018

1 reference

Yi-Jen Hung

1

1 reference

5 April 2018

Shi-Wen Kuo

2

1 reference

5 April 2018

Chao-Hung Wang

3

1 reference

5 April 2018

Hung-Yu Chang

4

1 reference

5 April 2018

Sheng-Hwu Hsieh

5

1 reference

5 April 2018

Harald Landen

6

1 reference

5 April 2018

publication date

1 January 2006

1 reference

5 April 2018

Clinical Drug Investigation

published in

1 reference

5 April 2018

volume

26

1 reference

5 April 2018

issue

10

1 reference

5 April 2018

page(s)

559-565

1 reference

5 April 2018

Efficacy and tolerability of acarbose in Asian patients with type 2 diabetes inadequately controlled with diet and sulfonylureas

cites work

1 reference

12 December 2020

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

12 December 2020

Epidemiologic study of type 2 diabetes in Taiwan

1 reference

12 December 2020

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria

1 reference

12 December 2020

Efficacy of acarbose in Chinese subjects with impaired glucose tolerance

1 reference

12 December 2020

Effect of acarbose on postprandial lipid metabolism in type 2 diabetes mellitus

1 reference

12 December 2020

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

1 reference

12 December 2020

Acarbose improves glycemic control in insulin-treated Asian type 2 diabetic patients: results from a multinational, placebo-controlled study.

1 reference

12 December 2020

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

1 reference

12 December 2020

The clinical implications of impaired glucose tolerance

1 reference

12 December 2020

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

1 reference

12 December 2020

Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group

1 reference

12 December 2020

New data on the rate of progression of impaired glucose tolerance to NIDDM and predicting factors.

1 reference

12 December 2020

Are randomized controlled trials sufficient evidence to guide clinical practice in type II (non-insulin-dependent) diabetes mellitus?

1 reference

12 December 2020

Safety and tolerability of acarbose in the treatment of type 1 and type 2 diabetes mellitus

1 reference

12 December 2020

Combining sulfonylureas and other oral agents

1 reference

12 December 2020

An Asian multicenter clinical trial to assess the efficacy and tolerability of acarbose compared with placebo in type 2 diabetic patients previously treated with diet. Asian Acarbose Study Group

1 reference

12 December 2020

Hyperglycemia and cardiovascular disease

1 reference

12 December 2020

The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease.

1 reference

12 December 2020

Safety and efficacy of acarbose in the treatment of Type 2 diabetes: data from a 5-year surveillance study

1 reference

12 December 2020

Acarbose in NIDDM patients with poor control on conventional oral agents. A 24-week placebo-controlled study

1 reference

12 December 2020

Diagnostic criteria of glucose intolerance and mortality

1 reference

12 December 2020

Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies

1 reference

12 December 2020

10.2165/00044011-200626100-00002

Identifiers

DOI

1 reference

5 April 2018

1 reference

5 April 2018